Improved targeted delivery of antisense oligonucleotide with an antibody mask
Open Access
- 28 October 2025
- journal article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (20)
Abstract
Antisense oligonucleotides (ASOs) are synthetic nucleic acid strands designed to modulate gene expression by binding to RNA transcripts. In brain diseases, transferrin receptor (TfR)-targeting antibody–ASO conjugates have shown promise for brain delivery of ASOs via transcytosis in preclinical studies. This enables the more patient friendly intravenous or subcutaneous administration of the compounds. However, these conjugates can exhibit faster plasma clearance and different peripheral pharmacokinetic profiles due to ASO modifications, such as phosphorothioate (PS) linkages and locked nucleic acids (LNAs). In this study, we employed an antibody recognizing LNA- and PS-modified ASOs independent of the base sequences as a cloaking module to mitigate these issues. Using Kutzneria albida transglutaminase (KTG) technology and click chemistry, we generated TfR antibody–ASO conjugates with covalently or noncovalently incorporated ASO binders. Additionally, a noncovalent carrier antibody approach was explored. These conjugates and complexes with additional ASO binder(s) show improved TfR-targeted cellular uptake, undergo transcytosis in cellular blood–brain barrier models, show less nonspecific cellular accumulation, and anticipated ASO activity.Keywords
Funding Information
- Roche Postdoctoral Fellowship
This publication has 39 references indexed in Scilit:
- How good are my data and what is the resolution?Acta Crystallographica Section D Structural Biology, 2013
- Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis TargetScience Translational Medicine, 2011
- Overview of theCCP4 suite and current developmentsActa Crystallographica Section D Structural Biology, 2011
- Features and development of CootActa Crystallographica Section D Structural Biology, 2010
- Locked Nucleic Acids: Promising Nucleic Acid Analogs for Therapeutic ApplicationsChemistry & Biodiversity, 2010
- RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic PlatformAnnual Review of Pharmacology and Toxicology, 2010
- Integration, scaling, space-group assignment and post-refinementActa Crystallographica Section D Structural Biology, 2010
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic indexNature Biotechnology, 2008
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- Targeting Rat Anti-Mouse Transferrin Receptor Monoclonal Antibodies through Blood-Brain Barrier in MouseThe Journal of Pharmacology and Experimental Therapeutics, 2000